| Literature DB >> 30975670 |
Jing Chai1,2, Caroline Coope3,4, Jing Cheng1,2, Isabel Oliver3,4, Anthony Kessel5, Zhi Hu1, DeBin Wang2.
Abstract
OBJECTIVE: To describe help seeking behaviour from a medical doctor and antimicrobial use for common infections among rural residents of Anhui province, China.Entities:
Keywords: antimicrobial resistance; antimicrobial use; pharmacoepidemiology; prescription; self-medication
Year: 2019 PMID: 30975670 PMCID: PMC6500192 DOI: 10.1136/bmjopen-2018-024856
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Sociodemographic characteristics and reported symptoms of common infections among rural residents (n=2611)
| Subgroups | Total in sample, | Age-range in years, n (%) | |||||
| ≤30 | 31–40 | 41–50 | 51–60 | 61–70 | ≥71 | ||
| Sex | |||||||
| Male | 1082 (41.4) | 76 (7.0) | 106 (9.8) | 244 (22.6) | 190 (17.6) | 289 (26.7) | 177 (16.4) |
| Female | 1529 (58.6) | 164 (10.7) | 186 (12.2) | 382 (25.0) | 327 (21.4) | 309 (20.2) | 161 (10.5) |
| Education | |||||||
| No formal education | 865 (33.1) | 1 (0.1) | 19 (2.2) | 126 (14.6) | 194 (22.4) | 321 (37.1) | 204 (23.6) |
| Primary school | 694 (26.6) | 7 (1.0) | 58 (8.4) | 239 (34.4) | 122 (17.6) | 189 (27.2) | 79 (11.4) |
| Middle school | 778 (29.8) | 124 (15.9) | 163 (21.0) | 221 (28.4) | 152 (19.5) | 72 (9.3) | 46 (5.9) |
| Higher school | 274 (10.5) | 108 (39.4) | 52 (19.0) | 40 (14.6) | 49 (17.9) | 16 (5.8) | 9 (3.3) |
| Health insurance | |||||||
| Insured | 2558 (98.3) | 231 (9.0) | 290 (11.3) | 612 (23.9) | 507 (19.8) | 587 (22.9) | 331 (12.9) |
| Uninsured | 45 (1.7) | 7 (15.6) | 1 (2.2) | 11 (24.4) | 10 (22.2) | 9 (20.0) | 7 (15.6) |
| ARKS* (max score 6) | |||||||
| ≥3 score | 317 (12.1) | 81 (25.6) | 69 (21.8) | 85 (26.8) | 43 (13.6) | 31 (9.8) | 8 (2.5) |
| 1–2 score | 1408 (53.9) | 141 (10.0) | 175 (12.4) | 368 (26.1) | 289 (20.5) | 295 (21.0) | 140 (9.9) |
| No ARKS | 886 (33.9) | 18 (2.0) | 48 (5.4) | 173 (19.5) | 185 (20.9) | 272 (30.7) | 190 (21.4) |
| Acute respiratory tract infections† | |||||||
| Yes | 2223 (85.1) | 222 (10.0) | 266 (12.0) | 535 (24.1) | 435 (19.6) | 495 (22.3) | 270 (12.1) |
| No | 388 (14.9) | 18 (4.6) | 26 (6.7) | 91 (23.5) | 82 (21.1) | 103 (26.5) | 68 (17.5) |
| Gastrointestinal tract infections‡ | |||||||
| Yes | 425 (16.3) | 60 (14.1) | 60 (14.1) | 89 (20.9) | 84 (19.8) | 84 (19.8) | 48 (11.3) |
| No | 2186 (83.7) | 180 (8.2) | 232 (10.6) | 537 (24.6) | 433 (19.8) | 514 (23.5) | 290 (13.3) |
| Urinary tract infections‡ | |||||||
| Yes | 133 (5.1) | 3 (2.3) | 14 (10.5) | 39 (29.3) | 29 (21.8) | 34 (25.6) | 14 (10.5) |
| No | 2477 (94.9) | 237 (9.6) | 278 (11.2) | 586 (23.7) | 488 (19.7) | 564 (22.8) | 324 (13.1) |
*Antimicrobials-related knowledge score.
†Most recent episode within the past 12 months.
‡Episode within the past 3 months.
ARKS, antimicrobial-related knowledge score.
Help-seeking from medical doctor following reported symptoms of selected common infections
| Service use | ARTIs* (n=2223) | Gastrointestinal tract infections (GTIs)† (n=425) | UTIs‡(n=133) | |||
| n | % | n | % | n | % | |
| (1) Help-seeking from a medical doctor (Q2.3, Q2.21 and Q2.37) | ||||||
| Yes | 1319 | 59.4 | 118 | 27.8 | 56 | 42.1 |
| No | 902 | 40.6 | 307 | 72.2 | 77 | 57.9 |
| Not stated | 2 | NA | 0 | NA | 0 | NA |
| (2) Days until complete recovery after onset of symptoms (Q2.18, Q2.34 and Q2.50) | ||||||
| Day 1 | 52 | 2.4 | 98 | 25.9 | 6 | 4.7 |
| Day 2 | 262 | 12.3 | 114 | 30.2 | 18 | 14.1 |
| Day 3 | 520 | 24.4 | 65 | 17.2 | 19 | 14.8 |
| Day 4 | 301 | 14.1 | 30 | 7.9 | 10 | 7.8 |
| Day 5 | 167 | 7.8 | 12 | 3.2 | 5 | 3.9 |
| Day 6 | 64 | 3.0 | 4 | 1.1 | 1 | 0.8 |
| Day 7 | 365 | 17.1 | 8 | 2.1 | 11 | 8.6 |
| Day 8+ | 231 | 10.9 | 7 | 1.9 | 21 | 16.4 |
| Not yet recovered | 167 | 7.8 | 40 | 10.6 | 37 | 28.9 |
| Not stated | 94 | NA | 47 | NA | 5 | NA |
| (3) Days until first help-seeking from a medical doctor after onset of symptoms‡ (Q2.6, Q2.24 and Q2.40) | ||||||
| Day 1 | 257 | 19.8 | 41 | 35.7 | 4 | 7.5 |
| Day 2 | 471 | 36.3 | 46 | 40.0 | 19 | 35.9 |
| Day 3 | 339 | 26.1 | 13 | 11.3 | 12 | 22.7 |
| Day 4+ | 230 | 17.7 | 15 | 13.0 | 18 | 34.0 |
| Not stated | 22 | NA | 3 | NA | 3 | NA |
*Most recent episode within the past 12 months.
†Episode within the past 3 months.
‡Includes only those who stated ‘yes’ to use of professional healthcare service.
ARTI, acute respiratory tract infection; NA, not applicable; Q plus a number, the reference number of question used in the questionnaire; UTI, urinary tract infection.
Reported use of prescribed antimicrobials for common infections following help-seeking from a medical doctor
| Antimicrobial use | ARTIs* (n=1319) | GTIs† (n=118) | UTIs† (n=56) | |||
| n | % | n | % | n | % | |
| (1) Respondents with clear memory of receiving prescribed oral antimicrobials (Q2.7, Q2.25 and Q2.41) | ||||||
| Yes | 638 | 72.7 | 34 | 49.3 | 32 | 74.4 |
| No | 240 | 27.3 | 33 | 50.7 | 11 | 25.6 |
| Not clear | 409 | NA | 43 | NA | 12 | NA |
| Not stated | 32 | NA | 8 | NA | 1 | NA |
| (2) Respondents with clear memory of receiving an intravenous antimicrobial (Q2.10, Q2.27 and Q2.43) | ||||||
| Yes | 705 | 54.7 | 48 | 42.5 | 12 | 22.6 |
| No | 584 | 45.3 | 65 | 57.5 | 41 | 77.4 |
| Not clear | 17 | NA | 3 | NA | 3 | NA |
| Not stated | 13 | NA | 2 | NA | 0 | NA |
| (3) Respondents with clear memory of receiving oral/intravenous antimicrobials (Q2.7, Q2.10, Q2.25 Q2.27, Q2.41 and Q2.43) | ||||||
| Yes | 1051 | 94.5 | 67 | 81.7 | 38 | 70.4 |
| No | 61 | 5.5 | 15 | 18.3 | 16 | 29.6 |
| Not clear | 197 | NA | 32 | NA | 1 | NA |
| Not stated | 10 | NA | 4 | NA | 1 | NA |
| (4) Prescribed oral/intravenous antimicrobials by days after onset of symptoms when the first professional service seeking took place‡ (Q2.6, Q2.7, Q2.10, Q2.24, Q2.25 Q2.27, Q2.40, Q2.41 and Q2.43) | ||||||
| Day 1 | 178 | 91.8 | 20 | 80.0 | 1 | 25.0 |
| Day 2 | 383 | 93.9 | 27 | 79.4 | 14 | 77.8 |
| Day 3 | 286 | 96.0 | 8 | 88.9 | 8 | 66.7 |
| Day 4+ | 189 | 95.9 | 12 | 85.7 | 13 | 76.5 |
| Not stated | 15 | NA | 0 | NA | 2 | NA |
*Most recent episode within the past 12 months.
†Episode within the past 3 months.
‡Includes only those who stated ‘yes’ to clearly remembering receiving oral or intravenous antimicrobials or both; oral/intravenous antimicrobials mean oral or intravenous antimicrobials or both.
ARTI, acute respiratory tract infection; GTI, gastrointestinal tract infection; NA, not applicable; Q plus a number, the reference number of question used in the questionnaire; UTI, urinary tract infection.
Use of self-medication with antimicrobials for suspected infections
| Self-medication | ARTIs* (n=2223) | GTIs† (n=425) | UTIs† (n=133) | |||
| N | % | N | % | N | % | |
| (1) Respondents who bought medicines for suspected infection without prescriptions (Q2.14, Q2.30 and Q2.46) | ||||||
| Yes | 658 | 29.8 | 83 | 19.8 | 33 | 24.8 |
| No | 1551 | 70.2 | 337 | 80.2 | 100 | 75.2 |
| Not stated | 14 | NA | 5 | NA | 0 | NA |
| (2) Antimicrobials bought for suspected infection without prescriptions‡ (Q2.16, Q2.32 and Q2.48) | ||||||
| Yes | 354 | 62.5 | 36 | 51.4 | 22 | 72.7 |
| No | 212 | 37.5 | 34 | 48.6 | 6 | 27.3 |
| Not stated | 92 | NA | 13 | NA | 5 | NA |
| (3) Respondents who bought antimicrobials for suspected infection without prescriptions (Q2.14, Q2.16, Q2.30, Q2.32, Q2.46 and Q2.48) | ||||||
| Yes | 354 | 16.7 | 36 | 8.8 | 22 | 17.2 |
| No | 1763 | 83.3 | 371 | 91.2 | 106 | 82.8 |
| Not stated | 106 | NA | 18 | NA | 5 | NA |
| (3) Use of antimicrobials leftover from previous illness or given by relatives (Q2.17, Q2.33 and Q2.49) | ||||||
| Yes | 290 | 13.4 | 43 | 10.8 | 10 | 7.6 |
| No | 1872 | 86.6 | 356 | 89.2 | 122 | 92.4 |
| Not stated | 61 | NA | 26 | NA | 1 | NA |
*Most recent episode within the past 12 months.
†Episode within the past 3 months.
‡Includes only those who stated ‘yes’ to buy medicines for suspected infection without prescriptions.
ARTI, acute respiratory tract infection; GTI, gastrointestinal tract infection; NA, not applicable; Q plus a number, the reference number of question used in the questionnaire; UTI, urinary tract infection.
Help-seeking from a medical doctor and use of prescribed antimicrobials following respiratory tract infections by type of health insurance and antimicrobial-related knowledge score
| Category | Help-seeking | Help-seeking at village clinic | Help-seeking at township or higher level (Q2.5, n=1317) | Use of prescribed oral/IV antimicrobials (Q2.7 and Q2.10, n=1111) | Use of prescribed oral antimicrobials (Q2.7, n=877) | Use of prescribed IV antimicrobials (Q2.10, n=1288) | ||||||||||||
| n | OR (95% CI) | P value | n | OR (95% CI) | P value | n | OR (95% CI) | P value | n | OR (95% CI) | P value | n | OR (95% CI) | P value | n | OR (95% CI) | P value | |
| Gender | ||||||||||||||||||
| Female | 1352 | Ref.* | 780 | Ref. | 780 | Ref. | 666 | Ref. | 531 | Ref. | 764 | Ref. | ||||||
| Male | 864 | 1.40 (1.15 to 1.70) | <0.01 | 537 | 0.83 (0.61 to 1.13) | 0.24 | 537 | 1.15 (0.84 to 1.56) | 0.39 | 445 | 1.26 (0.70 to 2.27) | 0.44 | 346 | 1.13 (0.80 to 1.58) | 0.50 | 524 | 0.89 (0.70 to 1.15) | 0.38 |
| Age group (years) | ||||||||||||||||||
| ≤30 | 219 | Ref. | 107 | Ref. | 107 | Ref.* | 91 | Ref. | 73 | Ref.* | 106 | Ref.* | ||||||
| 31–40 | 265 | 0.89 (0.61 to 1.30) | 0.55 | 139 | 0.84 (0.42 to 1.68) | 0.42 | 139 | 0.99 (0.52 to 1.90) | 0.98 | 122 | 0.70 (0.21 to 2.31) | 0.56 | 108 | 1.90 (0.92 to 3.92) | 0.08 | 137 | 0.78 (0.46 to 1.32) | 0.35 |
| 41–50 | 534 | 0.77 (0.54 to 1.10) | 0.15 | 291 | 0.42 (0.21 to 0.86) | <0.01 | 291 | 0.58 (0.30 to 1.10) | 0.09 | 249 | 0.66 (0.21 to 2.09) | 0.48 | 209 | 1.42 (0.73 to 2.77) | 0.30 | 289 | 0.91 (0.55 to 1.48) | 0.69 |
| 51–60 | 435 | 0.82 (0.57 to 1.19) | 0.30 | 254 | 0.84 (0.42 to 1.65) | 0.14 | 254 | 1.12 (0.60 to 2.08) | 0.73 | 212 | 0.75 (0.22 to 2.53) | 0.64 | 173 | 1.16 (0.59 to 2.30) | 0.67 | 248 | 0.94 (0.57 to 1.56) | 0.82 |
| 61–70 | 494 | 0.93 (0.62 to 1.38) | 0.70 | 326 | 0.84 (0.41 to 1.71) | 0.25 | 326 | 1.22 (0.64 to 2.33) | 0.55 | 282 | 0.64 (0.18 to 2.23) | 0.48 | 210 | 0.59 (0.29 to 1.19) | 0.14 | 319 | 1.81 (1.07 to 3.07) | 0.03 |
| ≥71 | 269 | 1.30 (0.83 to 2.04) | 0.25 | 200 | 0.70 (0.32 to 1.53) | 0.19 | 200 | 1.24 (0.63 to 2.46) | 0.54 | 155 | 0.48 (0.13 to 1.82) | 0.28 | 104 | 0.77 (0.36 to 1.68) | 0.52 | 189 | 1.77 (1.00 to 3.11) | 0.05 |
| Education group | ||||||||||||||||||
| No formal education | 718 | Ref.* | 492 | Ref. | 492 | Ref. | 405 | Ref. | 302 | Ref. | 476 | Ref. | ||||||
| Primary school | 596 | 0.78 (0.61 to 1.00) | 0.05 | 370 | 1.04 (0.68 to 1.60) | 0.31 | 370 | 1.10 (0.76 to 1.59) | 0.62 | 317 | 0.70 (0.34 to 1.43) | 0.32 | 250 | 0.86 (0.57 to 1.29) | 0.46 | 364 | 0.98 (0.72 to 1.32) | 0.87 |
| Middle school | 658 | 0.58 (0.44 to 0.76) | <0.01 | 344 | 0.84 (0.50 to 1.41) | 0.22 | 344 | 0.85 (0.55 to 1.33) | 0.48 | 288 | 0.76 (0.33 to 1.79) | 0.53 | 235 | 0.80 (0.49 to 1.30) | 0.36 | 337 | 0.99 (0.70 to 1.40) | 0.94 |
| Higher school | 244 | 0.48 (0.33 to 0.70) | <0.01 | 111 | 1.23 (0.61 to 2.47) | 0.87 | 111 | 1.51 (0.83 to 2.76) | 0.18 | 101 | 0.61 (0.20 to 1.88) | 0.39 | 90 | 0.59 (0.30 to 1.16) | 0.12 | 111 | 1.25 (0.75 to 2.08) | 0.40 |
| Health insurance | ||||||||||||||||||
| Insured | 2178 | Ref.* | 1303 | Ref.* | 1303 | Ref.* | 1099 | Ref. | 868 | Ref. | 1274 | Ref. | ||||||
| Uninsured | 38 | 0.33 (0.17 to 0.66) | <0.01 | 14 | 0.17 (0.06 to 0.51) | <0.01 | 14 | 5.90 (1.99 to 17.47) | <0.01 | 12 | 0.55 (0.07 to 4.42) | 0.57 | 9 | 0.57 (0.15 to 2.20) | 0.42 | 14 | 0.77 (0.27 to 2.25) | 0.64 |
| ARKS | ||||||||||||||||||
| No ARKS | 726 | Ref.* | 498 | Ref. | 498 | 398 | Ref.* | 302 | Ref. | 482 | Ref. | |||||||
| 1–2 scores | 1208 | 0.77 (0.63 to 0.95) | 0.01 | 707 | 1.18 (0.82 to 1.71) | 0.05 | 707 | 1.33 (0.97 to 1.82) | 0.08 | 610 | 0.80 (0.42 to 1.50) | 0.48 | 484 | 1.13 (0.81 to 1.59) | 0.47 | 695 | 1.11 (0.86 to 1.43) | 0.41 |
| ≥3 scores | 282 | 0.42 (0.31 to 0.58) | <0.01 | 112 | 1.46 (0.78 to 2.76) | 0.11 | 112 | 1.30 (0.73 to 2.31) | 0.37 | 103 | 0.32 (0.13 to 0.78) | 0.01 | 91 | 1.16 (0.64 to 2.11) | 0.63 | 111 | 0.77 (0.48 to 1.21) | 0.25 |
Oral/IV antimicrobials mean oral or IV antimicrobials or both.
*P<0.05 for the variable in the overall regression model.
ARKS, antimicrobial-related knowledge score; IV, intravenous; Q plus a number, the reference number of question used in the questionnaire; Ref., reference.